US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

BIOTE CORP

us-stock
To Invest in {{usstockname}}
us-stock
$2.58 0.032(3.2%) BTMD at 04 Dec 2025 04:27 PM Medical Care Facilities
Lowest Today 2.495
Highest Today 2.58
Today’s Open 2.5
Prev. Close 2.5
52 Week High 6.90
52 Week Low 2.32
Day’s Range: Low 2.495 High 2.58
52-Week Range: Low 2.32 High 6.90
1 day return -
1 Week return -4.46
1 month return -10.45
3 month return -24.41
6 month return -27.6
1 year return -61.2
3 year return -39.38
5 year return -
10 year return -

Institutional Holdings

325 Capital LLC 14.35

Bandera Partners LLC 7.21

BlackRock Inc 5.55

Vanguard Group Inc 4.49

Vanguard Total Stock Mkt Idx Inv 2.63

iShares Russell 2000 ETF 2.12

Dimensional Fund Advisors, Inc. 1.95

Geode Capital Management, LLC 1.95

State Street Corp 1.58

Hillsdale Investment Management Inc. 1.33

Fidelity Small Cap Index 0.93

Northern Trust Corp 0.89

GlobeFlex Capital, L.P. 0.86

Vanguard Institutional Extnd Mkt Idx Tr 0.74

Jacobs Levy Equity Management, Inc. 0.70

Morgan Stanley - Brokerage Accounts 0.70

Los Angeles Capital Management LLC 0.63

Renaissance Technologies Corp 0.57

iShares Russell 2000 Value ETF 0.56

DFA US Micro Cap I 0.54

DFA US Small Cap I 0.52

Vanguard Russell 2000 ETF 0.44

Scotia Wealth Quant Glbl Sm Cp Eq Pl KM 0.43

Millennium Management LLC 0.41

Perritt Capital Management Inc. 0.40

Fidelity Extended Market Index 0.39

Rice Hall James & Associates, LLC 0.38

Bridgeway Capital Management, LLC 0.38

Marshall Wace Asset Management Ltd 0.38

State St Russell Sm Cap® Indx SL Cl I 0.37

AQR Capital Management LLC 0.35

Perritt MicroCap Opportunities Investor 0.32

Dimensional US Small Cap ETF 0.29

iShares Russell 2000 Growth ETF 0.28

Schwab Small Cap Index 0.24

NT R2000 Index Fund - NL 0.23

Bridgeway Ultra-Small Company 0.22

iShares Micro-Cap ETF 0.21

Extended Equity Market Fund K 0.19

NT R2000 Index Fund - DC - NL - 3 0.18

Market Status

Strong Buy: 5

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 119.63 M

PB Ratio 2.9604

PE Ratio 3.2468

Enterprise Value 156.90 M

Total Assets 122.37 M

Volume 122973

Company Financials

Annual Revenue FY23:184142000 184.1M, FY22:164957000 165.0M, FY21:139396000 139.4M, FY20:116568000 116.6M, FY19:109976000 110.0M

Annual Profit FY23:124846000 124.8M, FY22:110382000 110.4M, FY21:90579000 90.6M, FY20:71639000 71.6M, FY19:66411000 66.4M

Annual Net worth FY23:-2796000 -2.8M, FY22:1324000 1.3M, FY21:32619000 32.6M, FY20:29162000 29.2M, FY19:21287000 21.3M

Quarterly Revenue Q3/2025:47956000 48.0M, Q2/2025:48863000 48.9M, Q1/2025:48992000 49.0M, Q3/2024:51384000 51.4M, Q2/2024:49169000 49.2M

Quarterly Profit Q3/2025:34418000 34.4M, Q2/2025:34988000 35.0M, Q1/2025:36382000 36.4M, Q3/2024:36212000 36.2M, Q2/2024:33882000 33.9M

Quarterly Net worth Q3/2025:8188000 8.2M, Q2/2025:3185000 3.2M, Q1/2025:13718000 13.7M, Q3/2024:10702000 10.7M, Q2/2024:-6322000 -6.3M

Fund house & investment objective

Company Information biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Organisation Medical Care Facilities

Employees 217

Industry Medical Care Facilities

CEO Mr. Bret Christensen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right